Compounds for inhibiting &bgr;-amyloid peptide release and/or its synthesis
US6476263B1 · kind B1 · utility
1Cited by
11References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 3, 2001 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Apr 3, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06078
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.